Prosight Management »

Fortrea Hldgs shares owned by Prosight Management

Quarter-by-quarter ownership of Fortrea Hldgs (FTRE) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Fortrea Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Fortrea Hldgs held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fortrea Hldgs by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.0M 55k 18.65

More positions owned by Prosight Management

Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Intuitive Surgical Com New (ISRG)
Janux Therapeutics (JANX)
Roivant Sciences SHS (ROIV)
Icon SHS (ICLR)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Crinetics Pharmaceuticals In (CRNX)
Amicus Therapeutics (FOLD)
Dex (DXCM)
Shattuck Labs (STTK)
Zymeworks Del (ZYME)

View all positions for Prosight Management

Top funds holding Fortrea Hldgs

BlackRock
Vanguard Group
Goldman Sachs Group
Corvex Management
State Street Corporation
Sessa Capital IM
AQR Capital Management
FMR
Morgan Stanley
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Park West Asset Management
Geode Capital Management
Nuveen
Beck Mack & Oliver

View all funds holding Fortrea Hldgs